Foundation Medicine, Novartis partner up on companion diagnostics in oncology
The partnership will also enable Foundation Medicine to move into ex-US markets like Japan, where it is working with drugmaker Chugai.
Foundation Medicine launches liquid biopsy test
Chief Commercial Officer Tom Civik said he sees reimbursement of its NGS test as opening the door for liquid biopsy reimbursement as well.
Why Pharma Companies Should Look To Social Media For Better Patient Insight
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.
Merck, Foundation Medicine to build companion diagnostics for Keytruda
Companies to create tests for tissue-agnostic MSI-H and dMMR cancers using Foundation's next-generation sequencing platform.